InChI=1S/C81H150O17P2/c1-5-9-13-17-21-25-29-33-37-41-45-49-53-57-61-65-78(83)91-71-76(97-80(85)67-63-59-55-51-47-43-39-35-31-27-23-19-15-11-7-3)73-95-99(87,88)93-69-75(82)70-94-100(89,90)96-74-77(98-81(86)68-64-60-56-52-48-44-40-36-32-28-24-20-16-12-8-4)72-92-79(84)66-62-58-54-50-46-42-38-34-30-26-22-18-14-10-6-2/h33-40,75-77,82H,5-32,41-74H2,1-4H3,(H,87,88)(H,89,90)/b37-33-,38-34-,39-35-,40-36-/t76-,77-/m1/s1 |
TWHQNHQPSCPQNY-WVRHUKEESA-N |
CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP(O)(=O)OCC(O)COP(O)(=O)OC[C@@H](COC(=O)CCCCCCC\C=C/CCCCCCCC)OC(=O)CCCCCCC\C=C/CCCCCCCC)OC(=O)CCCCCCC\C=C/CCCCCCCC |
|
antigen
Any substance that stimulates an immune response in the body, such as through antibody production or by presentation to a T-cell receptor after binding to a major histocompability complex (MHC).
Escherichia coli metabolite
Any bacterial metabolite produced during a metabolic reaction in Escherichia coli.
(via cardiolipin )
(via phosphatidylglycerol )
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
(via cardiolipin )
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
(via cardiolipin )
(via phosphatidylglycerol )
|
|
View more via ChEBI Ontology
(9Z,21R,33R,44Z)-24,27,30-trihydroxy-24,30-dioxido-18,36-dioxo-19,23,25,29,31,35-hexaoxa-24λ5,30λ5-diphosphatripentaconta-9,44-diene-21,33-diyl (9Z,9'Z)bis-octadec-9-enoate
|
1',3'-bis{1,2-bis[(9Z)-octadec-9-enoyl]-sn-glycero-3-phospho}-sn-glycerol
|
1,1'2,2'-tetraoleoyl cardiolipin
|
ChEBI
|
1,1'2,2'-tetraoleoylcardiolipin
|
ChEBI
|
1,1'2,2'-tetraoleyl cardiolipin
|
ChEBI
|
1,1'2,2'-tetraoleylcardiolipin
|
ChEBI
|
tetraoleoyl cardiolipin
|
ChEBI
|
tetraoleoylcardiolipin
|
ChEBI
|
tetraoleylcardiolipin
|
ChEBI
|
9838546
|
Beilstein Registry Number
|
Beilstein
|
1627234
|
PubMed citation
|
Europe PMC
|
2390812
|
PubMed citation
|
Europe PMC
|
|